Skip to main content

Dr. Melotek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Melotek's full profile

Already have an account?

Education & Training

  • University of Chicago/University of Illinois College of Medicine at Chicago
    University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2013 - 2017
  • University of Chicago
    University of ChicagoInternship, Internal Medicine, 2012 - 2013
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 2012

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2026
  • IL State Medical License
    IL State Medical License 2015 - 2020
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society, 2011

Publications & Presentations

PubMed

Journal Articles

  • OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal Cancer  
    L Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology

Press Mentions

  • Role of Cetuximab Expands in Head and Neck Cancer
    Role of Cetuximab Expands in Head and Neck CancerJune 2nd, 2016

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations